EcoDrugPlus

Protein Kinase C Beta

Ensembl ID : ENSDCDG00000002783
Gene Symbol: PRKCB
3 Cross references
201 Possible Orthologues:

Protein Kinase C Beta Type

Ensembl ID : ENSDCDG00000003478
Gene Symbol: LOC114793471
3 Cross references
159 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSDCDG00000018207
Gene Symbol: PRKCD
3 Cross references
204 Possible Orthologues:

Protein Kinase C Delta Type-Like

Ensembl ID : ENSDCDG00000001344
Gene Symbol: LOC114770485
3 Cross references
207 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSDCDG00000021271
Gene Symbol: PRKCE
3 Cross references
268 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSDCDG00000022722
Gene Symbol: PRKCE
3 Cross references
251 Possible Orthologues:

Protein Kinase C Eta

Ensembl ID : ENSDCDG00000003024
Gene Symbol: PRKCH
3 Cross references
220 Possible Orthologues:

Protein Kinase C Eta Type-Like

Ensembl ID : ENSDCDG00000021886
Gene Symbol: LOC114802937
3 Cross references
161 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSDCDG00000028549
Gene Symbol: PRKCI
3 Cross references
270 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSDCDG00000033846
Gene Symbol: PRKCQ
3 Cross references
205 Possible Orthologues:

Protein Kinase C Zeta

Ensembl ID : ENSDCDG00000014491
Gene Symbol: PRKCZ
3 Cross references
205 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSDCDG00000000033
Gene Symbol: PRKD1
3 Cross references
214 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).